Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, September 13 '25)

Image
By G.M.

 


    Antiviral Res

  1. ICHIKAWA T, Tamura T, Nao N, Suzuki H, et al
    Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseases.
    Antiviral Res. 2025;242:106264.
    PubMed         Abstract available

  2. BI W, Zhu T, Xu Y, Chen Y, et al
    An engineered chimeric ACE2-HR2 peptide exhibits potent and broad-spectrum activity against SARS-CoV-2 variants.
    Antiviral Res. 2025;242:106265.
    PubMed         Abstract available

  3. TERATAKE Y, Okamura T, Ishizaka Y
    SMAD5 phosphorylation by ALK1 is modulated by the interaction of the spike protein of SARS-CoV-2 and angiotensin-converting enzyme 2.
    Antiviral Res. 2025;242:106261.
    PubMed         Abstract available

  4. YAO G, Shi X, Jiang H, Duan A, et al
    Design, synthesis, and biological evaluation of novel 6-aminoalkyl- and 7-heteroaryl substituted 7-deazapurine nucleoside analogs against SARS-CoV-2 Replication.
    Antiviral Res. 2025 Aug 1:106246. doi: 10.1016/j.antiviral.2025.106246.
    PubMed         Abstract available


    Drug Saf

  5. ORDONEZ-MENA JM, Kar D, Fan X, Ferreira F, et al
    Epidemiology of Thrombotic Thrombocytopenia Syndrome 2011 to 2022: English Sentinel Network Cohort Studies.
    Drug Saf. 2025;48:1161-1175.
    PubMed         Abstract available


    J Infect Dis

  6. BERMEJO-JAMBRINA M, Zaderer V, Eder J, Diem G, et al
    The Role of Enoxaparin in Influenza Virus Infections and Its Therapeutic Implications.
    J Infect Dis. 2025 Sep 10:jiaf470. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  7. FAN W, Zeng X, Chen Y, Yu Q, et al
    A recombinant Marek's disease vaccine candidate provides complete protection against infectious bursal disease virus and H9 subtype avian influenza virus in chickens.
    J Virol. 2025 Sep 11:e0114925. doi: 10.1128/jvi.01149.
    PubMed         Abstract available

  8. LAN R, Yang J, Li J, Li H, et al
    Continuous evolution of Eurasian avian-like H1N1 swine influenza viruses with pdm/09-derived internal genes enhances pathogenicity in mice.
    J Virol. 2025 Sep 8:e0043025. doi: 10.1128/jvi.00430.
    PubMed         Abstract available

  9. NAKANO M, Miyamoto S, Ohnishi C, Nogami C, et al
    Influenza A virus circumvents the innate immune response through the sequestration of double-stranded RNA.
    J Virol. 2025 Sep 8:e0073725. doi: 10.1128/jvi.00737.
    PubMed         Abstract available


    JAMA

  10. LIU Z, Zhang L, Jiang M
    Influenza and COVID-19 Multicomponent Vaccine in Adults.
    JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12222.
    PubMed        

  11. RUDMAN SPERGEL AK, Callendret B, Kostanyan L
    Influenza and COVID-19 Multicomponent Vaccine in Adults-Reply.
    JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12225.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  12. O'HALLORAN A, Habeck JW, Gilmer M, Threlkel R, et al
    Influenza-Associated Hospitalizations During a High Severity Season - Influenza Hospitalization Surveillance Network, United States, 2024-25 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2025;74:529-537.
    PubMed         Abstract available


    PLoS One

  13. MUHUNDHAKUMAR D, Clarke CS, Mills G, Ramsay AIG, et al
    Cohort profile: Design and methods for Project HERCULES (Healthcare Exemplar for Recovery from COVID 19 Using Linear Examination Systems): Multi-disciplinary implementation and evaluation of an asynchronous review clinic in NHS eye-care services.
    PLoS One. 2025;20:e0330863.
    PubMed         Abstract available

  14. CHOI J, Son G, Kim YS, Choi KH, et al
    Impact of depression, anxiety, and COVID-19 diagnosis on social isolation trajectories during the pandemic: A 3-year prospective cohort study.
    PLoS One. 2025;20:e0330118.
    PubMed         Abstract available

  15. RUDISILL C, Linvill K, Chupak A, Costa-Font J, et al
    Trust or money? Barriers to health and healthcare behavior during the COVID-19 pandemic.
    PLoS One. 2025;20:e0331600.
    PubMed         Abstract available

  16. GANGULY AP, Battaile JT, Harms M, Murray S, et al
    Charity coverage and decreased COVID-19 mortality among uninsured patients in Texas: A retrospective cohort study.
    PLoS One. 2025;20:e0330533.
    PubMed         Abstract available

  17. WILLEN SS, Mason KA, Wurtz HM, Karcher S, et al
    The Pandemic Journaling Project: A new dataset of first-person accounts of the COVID-19 pandemic.
    PLoS One. 2025;20:e0318397.
    PubMed         Abstract available

  18. LI Y, Sexton CL, Fitzpatrick A, Ruple A, et al
    An analysis of behavioral characteristics and enrollment year variability in 47,444 dogs entering the Dog Aging Project from 2020 to 2023.
    PLoS One. 2025;20:e0330257.
    PubMed         Abstract available

  19. DURANT EJ, Warton EM, Skarbinski J, Siqueiros MH, et al
    Predictors of health care utilization in patients with post-acute sequelae of COVID-19 (PASC).
    PLoS One. 2025;20:e0331370.
    PubMed         Abstract available

  20. GARBIN JRT, Leite FMC, Santos APBD, Dell'Antonio LS, et al
    Factors associated with prolonged hospitalizations for COVID-19 during the first three waves of the pandemic: Evidence from a Southeastern State of Brazil.
    PLoS One. 2025;20:e0332128.
    PubMed         Abstract available

  21. RABAGLIATI R, Benadof D, Thompson L, Garcia P, et al
    A prospective, multicenter study of invasive fungal disease caused by molds in children and adults in Chile.
    PLoS One. 2025;20:e0330426.
    PubMed         Abstract available

  22. KIM D, Kim T, Kim W, Youn H, et al
    When automation hits jobs: Entrepreneurship as an alternative career path.
    PLoS One. 2025;20:e0331244.
    PubMed         Abstract available

  23. ELSNER A, Mergl R, Allgaier AK, Hegerl U, et al
    Suicide rates in Germany in lockdown and non-lockdown phases during the COVID-19 pandemic in 2020/2021.
    PLoS One. 2025;20:e0331784.
    PubMed         Abstract available

  24. KIM J, Ewing CR, Larson A, Illapperuma-Wood C, et al
    Incidence of depression and anxiety in children and adolescents following COVID-19 infection.
    PLoS One. 2025;20:e0331984.
    PubMed         Abstract available

  25. MURPHY M, Friciu M, Roullin VG, Leclair G, et al
    Propofol emulsification in Intralipid and SMOFlipid: A promising alternative in response to future shortages.
    PLoS One. 2025;20:e0331651.
    PubMed         Abstract available

  26. XIA B, Pierce BS, Perrin PB
    Examining models of telemedicine use among U.S. physicians during the COVID-19 pandemic.
    PLoS One. 2025;20:e0331832.
    PubMed         Abstract available

  27. DELL'ANTONIO CSDS, Bierrenbach AL
    Epidemiological patterns of SARS-CoV-2 reinfections in Espirito Santo, Brazil: A population-based analysis using integrated surveillance and vaccination data.
    PLoS One. 2025;20:e0331771.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  28. LINOS E, Lasky-Fink J, Dorie V, Rothstein J, et al
    Interventions to bolster benefits take-up: Assessing intensity, framing, and targeting of government outreach.
    Proc Natl Acad Sci U S A. 2025;122:e2504747122.
    PubMed         Abstract available

  29. JIANG Z, Pan W, Chen Y, Zhou D, et al
    ApoD mediates age-associated increase in vulnerability to influenza virus infection.
    Proc Natl Acad Sci U S A. 2025;122:e2423973122.
    PubMed         Abstract available


    Vaccine

  30. HUANG YT, Tsou TP, Kuo SH, Huang YT, et al
    Assessment of influenza vaccine effectiveness among the elderly in Taiwan using population-based registry data for the 2023-2024 season.
    Vaccine. 2025;64:127690.
    PubMed         Abstract available

  31. BARBERIA LG, Seelaender ICR, Carvalho RJ, de Moraes JC, et al
    Caregivers' attitudes toward school-based vaccination programs: A comparison of COVID-19, HPV, influenza, and dengue vaccines in Brazil.
    Vaccine. 2025;64:127709.
    PubMed         Abstract available

  32. SANFTENBERG L, Kraeker L, Walter F, Tsiligianni I, et al
    Associations between common mental disorders and vaccination readiness against seasonal influenza and Covid-19 of chronically ill adult patients in primary care - a systematic review.
    Vaccine. 2025;64:127682.
    PubMed         Abstract available


    Virology

  33. SILVA MO, Daher IP, Oda Ibrahim CH, de Souza EE, et al
    Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants.
    Virology. 2025;611:110629.
    PubMed         Abstract available

  34. LU CY, Lai PY, Huang JM, Chang LY, et al
    Dual targeting of the Wnt and DNAJB6/MRJ regulatory loop as an anti-RSV strategy.
    Virology. 2025;611:110641.
    PubMed         Abstract available

  35. LUCINI PAIONI A, Donnici L, Nodari R, Longo Minnolo M, et al
    A rapid and robust luciferase-based reporter system to assess SARS-CoV-2 protease activity.
    Virology. 2025;611:110659.
    PubMed         Abstract available

  36. RAVINDRAN C, Mukherjee S
    Zebrafish as a model for SARS-CoV-2 infection, pathogenesis, transmission, and drug screening.
    Virology. 2025;611:110662.
    PubMed         Abstract available

  37. CHINNA P, Blumenthal MJ, Lambarey H, Jennings L, et al
    Assessment of gamma-herpesvirus infection dynamics in non-hospitalised people living with HIV during the COVID-19 pandemic in South Africa.
    Virology. 2025;611:110666.
    PubMed         Abstract available

  38. KIM KH, Hwang HS, Lee Y, Jung YJ, et al
    Interferon-gamma receptor signaling is critical for balanced immune activation and protection against influenza after vaccination.
    Virology. 2025;612:110674.
    PubMed         Abstract available

  39. QIAO Y, Tang M, Du M, Zhao C, et al
    H5N1 influenza virus-like particles based on BEVS induce robust functional antibodies and immune responses.
    Virology. 2025;612:110672.
    PubMed         Abstract available

  40. PAWAR SD, Tare DS, Keng SS, Walimbe AM, et al
    Tracing the possible origins of the clade 2.3.4.4b highly pathogenic avian influenza H5Nx viruses from India.
    Virology. 2025 Aug 29:110654. doi: 10.1016/j.virol.2025.110654.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »